No abstract

The aim was to evaluate for 75 days the impact on production of the remaining burden of ivermectin (IVM)-resistant parasites in naturally infected feedlot calves. The herds came from tick-infested areas of cattle breeding where the systematic use of IVM to control tick increases the gastrointestinal parasites resistant to this drug. This investigation was carried out in two commercial feedlots in Buenos Aires province. In feedlot A, two groups of 35 animal each received IVM 1% and the other received ricobendazole (RBZ) 10% respectively. The same was done in feedlot B. On day 0, two groups of 35 animals were made in feedlots A and B. Fecal samples were taken on days 0, 22, 54 and 75 pos-treatment (PT), and body weight was registered, from each animal. Fecal samples were processed for individual count of eggs per gram (EPG) and pooled fecal culture was carried out for identiϐication of the parasite genus in each sampling. Fecal egg count reduction test (FECR) was calculated on day 22 PT. The study design used was a totally randomized block, with commercial feedlot and sex as block variables. For data analysis, a mixed model of the SAS statistical program was used. The FECR average on day 22 was 28.4% in the IVM group, and 94,2 % in the RBZ group . From this date on, signiϐicant differences in EPG were kept until day 54. EPG counts were only equal near the end of the trial, on day 75 (p=0.16). In both commercial feedlots, especially in the IVM group, Cooperia spp. was the most prevalent parasite in the fecal cultures. Signiϐicant differences in weight (P<0.01) on post-treatment day 75 was found between the average weight in the RBZ and the IVM group (246 vs. 238 kg respectively), what means a difference of 8.3% in gains. The importance for production in the antiparasite failure treatment in commercial feedlots was demonstrated, and the need of pos-treatment controls to evaluate the efϐicacy of the antiparasitic administered is emphasized.

No abstract

No abstract

El objetivo del presente estudio fue evaluar el efecto del tratamiento metafiláctico con oxitetraciclina (OTC), a simple y doble dosis, en bovinos con alto riesgo de padecer enfermedad respiratoria bovina (ERB). El estudio se realizó en un establecimiento de engorde a corral donde se utilizaron 2.754 terneros que fueron considerados de alto riesgo de padecer ERB. Se utilizó un diseño en bloque completamente al azar donde se consideró al animal como la unidad experimental y el corral (n=10) como bloque. Se formaron tres grupos experimentales: 1- control (CTL) el cual permaneció sin tratamiento, 2- recibió OTC 20 mg/kg SC (OTC20) y 3- recibió OTC 40 mg/kg SC (OTC40). El riesgo de ERB fue evaluado a través de una regresión logística. Los animales del grupo CTL tuvieron 2,85 y 7,14 veces más chances de enfermarse de ERB que los animales de los grupos OTC20 y OTC40 respectivamente (p<0,001). En conclusión, el tratamiento metafiláctico con OTC es útil para reducir el riesgo de padecer ERB en engorde a corral, siendo su efecto mayor cuando se aplica a la dosis de 40 mg/kg.